A Phase I Study of Carboplatin, Taxol[Superscript TM], Etoposide, and Cyclophosphamide (CTEC) with Filgrastim as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer (Meeting abstract)
A Phase I Study of Carboplatin, Taxol[Superscript TM], Etoposide, and Cyclophosphamide (CTEC) with Filgrastim as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer (Meeting abstract). 1999 Asco Meeting. 1999; ASCO(abstract 1417).